Status: Not yet recruiting
Clinical Correlation Evaluation of the LIVERFASt Test for Diagnosing Important Liver Lesions of Fibrosis and Steatosis Against Magnetic Resonance Elastography (MRE) for Liver Fibrosis and MR-based Assessment of Steatosis, in Adult US Population.
This is a retrospective cross-sectional research intended to explore the utility of LIVERFASt in the clinical pathways for the detection of liver fibrosis and steatosis in comparison with the Magnetic Resonance Elastography (MRE) and MRct1 fibrosis classification (historical records) and to assess LIVERFASt performance for MR steatosis assessment in an United States adult miscellaneous population with available (historical) MR intracellular fat fraction assessment (ICFF) from a single tertiary US clinic.
Participants needed: 100
Trial details
Age: 18-90Biological sex: AllType: ObservationalSponsor: Fibronostics USA, IncUpdated: Mar 13, 2025Locations: 1Duration: 2 Days
Eligibility criteria
available historical report of MRE and LIVERFASt test [+2]
Participants identified as having risk factors for false positive/negative resul... [+1]